According to a new report North America Intragastric Balloon Market, published by KBV research, the North America Intragastric Balloon Market would witness market growth of 11.6% CAGR during the forecast period (2020-2026).
The US market dominated the North America Pill Form Market by Country in 2019, and would continue to be a dominant market till 2026. The Canada market would experience a CAGR of 15.4% during (2020 - 2026). Additionally, The Mexico market would witness a CAGR of 15.2% during (2020 - 2026).
The Saline Filled market dominated the Canada Intragastric Balloon Market by Filling Material in 2019, thereby, achieving a market value of $4472.1 Thousands by 2026. The Gas Filled market is expected to witness highest CAGR of 13.9% during (2020 - 2026).
The Single market dominated the Mexico Intragastric Balloon Market by Type in 2019, growing at a CAGR of 12.4 % during the forecast period. The Dual market is exhibiting a CAGR of 13.5% during (2020 - 2026). Additionally, The Triple market is would showcase highest CAGR of 13.5% during (2020 - 2026).
Report Structural Insights: https://www.kbvresearch.com/north-america-intragastric-balloon-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Sientra, Inc. (Silimed, Inc.), Apollo Endosurgery, Inc., Obalon Therapeutics, Inc., ReShape Lifesciences Inc., Allurion Technologies, Inc., Helioscopie SA (Sante Actions Group), Districlass Medical SA, Spatz FGIA, Inc., Duomed Group (Life Partners Europe), Medsil.
By Administration
By Type
By Filling Material
By End Use
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
